CD8A and neoplasm: In this study, we standardized a mIHC panel for PanCK (tumor cells), CD8 (T cells), PD-1, and TIM-3 to evaluate the infiltration of CD8+ cytotoxic T lymphocytes (CTL) and the status of immune checkpoints (Fig. 1B).